Asklepios BioPharmaceutical (AskBio) and the University of North Carolina at Chapel Hill (UNC) have entered into an agreement…
Articles by Marisa Wexler, MS
A new rat model of Angelman syndrome (AS) involves complete deletion of the maternal UBE3A gene, which causes multiple behavioral…
A conceptual model describing how Angelman syndrome (AS) tends to manifest and affect a person with Angelman and those…
Nutrition is an important but under-discussed aspect of care in Angelman syndrome (AS), according to a case report that described…
A clinical trial is evaluating the safety and tolerability of a nutritional formulation containing the ketone beta-hydroxybutyrate (BHB) as…
A first patient has been randomized in the NEPTUNE trial, which is testing oral OV101 (gaboxadol) as a potential treatment…
Angelman syndrome is caused by a lack of functional UBE3A gene in the brain. Thus, getting brain cells to…
A new study reports differences in brain activity among Angelman syndrome patients whose disease arises because of changes in the …